Chris Ullum, Medical Science Liaison at Arvinas

Chris Ullum

Medical Science Liaison at Arvinas | Denver, Colorado, United States

Profile last verified June 2026
Pharmaceuticals Verified Profile Denver, Colorado, United States University of Kentucky
Verified

Personal Email

***@insightbb.com

Personal • High Confidence

Phone Number

(303) ***-*288

United States • Phone

Free account · No credit card · 5 profiles/month

Chris Ullum Socials
Chris Ullum Work Experience

Medical Science Liaison at Arvinas in August 2024 - Present

Senior Medical Science Liaison at Bristol Myers Squibb in November 2023 - August 2024

Medical Science Liaison, Immuno-Oncology at Bristol Myers Squibb in September 2020 - August 2024

See more See less

Postdoctoral Fellowship (Medical Affairs and Scientific Communications) at ECIR Medical Communications in July 2019 - September 2020

Pharmacist Intern at Norton Healthcare in May 2015 - June 2019

Chris Ullum Education

University of Kentucky

University of Kentucky College of Pharmacy

Chris Ullum Skills
Customer Service Microsoft Office Microsoft Word PowerPoint Leadership Microsoft Excel Public Speaking Sales Time Management Social Networking Marketing Teamwork Management Event Planning Strategic Planning Snakes Microsoft PowerPoint Translational Research Oncology Cancer Biochemistry Molecular Biology Teaching Data Analysis
About Chris Ullum’s Current Company
Arvinas

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its PROTAC Discovery Engine to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; and ARV-102, targeting LRRK2 for neurodegenerative disorders. Based in the biotech hub of New Haven, CT, Arvinas is driven by an industry-leading team dedicated to improving the lives of people living with serious diseases. For more information, visit www.arvinas.com. Community Guidelines: http://bit.ly/ArvinasCG

Discover more about Arvinas
Chris Ullum’s Colleagues
Debby Nickischer

Debby Nickischer

Wallingford, Connecticut, United States

Senior IT Capability Manager-Biology at Arvinas

Senior IT Capability Manager-Biology at Arvinas
(September 2023 – Present)

Cheryl Fitzer-attas

Cheryl Fitzer-attas

Monroe, New Jersey, United States

Clinical Research | Medical Affairs | Bus Dev | Communications | Digital Health | AI in Healthcare | Clinical, Patient-Reported, Digital Outcomes | Neurology | Immunology | Oncology | Rare Disease |

We provide services related to: Clinical Research, Medical Affairs, Communications, Life Cycle Management, and Business Development - for the Life Sciences, Health Tech & Medical Cannabis Industries. You can reach us at [email protected]

Joseph Reo

Joseph Reo

New Haven, Connecticut, United States

Senior Director at Arvinas

Formulation, biopharmaceutics and processing advisement based on 36 years experience in Big Pharma, materials science and regulatory science. "More learning happens through failure than success."

Milky Florent

Milky Florent

New York, New York, United States

Global Regulatory Affairs & Strategy Executive | End-to-End Drug Development & Commercialization | Biopharmaceuticals Therapeutics

Executive Director, Regulatory Affairs at Arvinas
(Oct 2024 – Present)

Fatiha Elsafy

Fatiha Elsafy

Potomac, Maryland, United States

Executive Director, Clinical Operations

Senior Director, Clinical Operations Lead- BeOne Medicines USA Inc at BeOne Medicines
(Aug 2022 – Present)

Janet Wang

Janet Wang

Boston, Massachusetts, United States

Vice President, Head of Translational Sciences at Arvinas

Lead and manage Translational Sciences group, oversee translational sciences/medicine including preclinical translational research, translational biomarker and precision medicine from end-to-end clinical biomarker to CDx strategy and development across multiple programs to sup...

Search similar profiles
Frequently asked questions about Chris Ullum

What is Chris Ullum email address?

Email Chris Ullum at [email protected], [email protected] and [email protected]. This email is the most updated Chris Ullum's email found in 2026.

How to contact Chris Ullum?

To contact Chris Ullum send an email to [email protected], [email protected] or [email protected]. (updated on June 2026)

What company does Chris Ullum work for?

Chris Ullum works for Arvinas.

What is Chris Ullum's role at Arvinas?

Chris Ullum is Medical Science Liaison

What industry does Chris Ullum work in?

Chris Ullum works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free